Narcolepsy treatment: pharmacological and behavioral strategies in adults and children

Christian Franceschini, Fabio Pizza, Elena Antelmi, Maria Claudia Folli, Giuseppe Plazzi

Research output: Contribution to journalReview article

Abstract

Narcolepsy is a disabling, rare, and chronic sleep disorder, currently classified as distinct central nervous system hypersomnia in narcolepsy type 1 (NT1) and narcolepsy type 2 (NT2). Although today a reliable pathogenic hypothesis identifies the cause of NT1 as an autoimmune process destroying hypocretin-producing cells, there is no cure for narcolepsy, and the symptomatic pharmacological available treatments are not entirely effective for all symptoms. Behavioral therapies play a synergistic role in the disease treatment. We here review the available therapeutic options for narcolepsy, including symptomatic pharmacological treatments as well as behavioral and psychosocial interventions that could help clinicians improve the quality of life of patients with narcolepsy in adulthood and childhood.

Original languageEnglish
JournalSleep and Breathing
DOIs
Publication statusE-pub ahead of print - Jan 1 2019

Fingerprint

Narcolepsy
Pharmacology
Disorders of Excessive Somnolence
Play Therapy
Therapeutics
Central Nervous System
Quality of Life

Keywords

  • Adults
  • Behavioral treatment
  • Children
  • Narcolepsy
  • Pharmacological treatment
  • Psychological treatment

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Clinical Neurology

Cite this

Narcolepsy treatment : pharmacological and behavioral strategies in adults and children. / Franceschini, Christian; Pizza, Fabio; Antelmi, Elena; Folli, Maria Claudia; Plazzi, Giuseppe.

In: Sleep and Breathing, 01.01.2019.

Research output: Contribution to journalReview article

@article{0f7ce94f9fbd4f8da1e02d09c4da9c22,
title = "Narcolepsy treatment: pharmacological and behavioral strategies in adults and children",
abstract = "Narcolepsy is a disabling, rare, and chronic sleep disorder, currently classified as distinct central nervous system hypersomnia in narcolepsy type 1 (NT1) and narcolepsy type 2 (NT2). Although today a reliable pathogenic hypothesis identifies the cause of NT1 as an autoimmune process destroying hypocretin-producing cells, there is no cure for narcolepsy, and the symptomatic pharmacological available treatments are not entirely effective for all symptoms. Behavioral therapies play a synergistic role in the disease treatment. We here review the available therapeutic options for narcolepsy, including symptomatic pharmacological treatments as well as behavioral and psychosocial interventions that could help clinicians improve the quality of life of patients with narcolepsy in adulthood and childhood.",
keywords = "Adults, Behavioral treatment, Children, Narcolepsy, Pharmacological treatment, Psychological treatment",
author = "Christian Franceschini and Fabio Pizza and Elena Antelmi and Folli, {Maria Claudia} and Giuseppe Plazzi",
note = "Ricercatori distaccati presso IRCCS a seguito Convenzione esclusiva con Universit{\`a} di Bologna (Pizza Fabio, Antelmi Elena, Plazzi Giuseppe).",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s11325-019-01894-4",
language = "English",
journal = "Sleep and Breathing",
issn = "1520-9512",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Narcolepsy treatment

T2 - pharmacological and behavioral strategies in adults and children

AU - Franceschini, Christian

AU - Pizza, Fabio

AU - Antelmi, Elena

AU - Folli, Maria Claudia

AU - Plazzi, Giuseppe

N1 - Ricercatori distaccati presso IRCCS a seguito Convenzione esclusiva con Università di Bologna (Pizza Fabio, Antelmi Elena, Plazzi Giuseppe).

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Narcolepsy is a disabling, rare, and chronic sleep disorder, currently classified as distinct central nervous system hypersomnia in narcolepsy type 1 (NT1) and narcolepsy type 2 (NT2). Although today a reliable pathogenic hypothesis identifies the cause of NT1 as an autoimmune process destroying hypocretin-producing cells, there is no cure for narcolepsy, and the symptomatic pharmacological available treatments are not entirely effective for all symptoms. Behavioral therapies play a synergistic role in the disease treatment. We here review the available therapeutic options for narcolepsy, including symptomatic pharmacological treatments as well as behavioral and psychosocial interventions that could help clinicians improve the quality of life of patients with narcolepsy in adulthood and childhood.

AB - Narcolepsy is a disabling, rare, and chronic sleep disorder, currently classified as distinct central nervous system hypersomnia in narcolepsy type 1 (NT1) and narcolepsy type 2 (NT2). Although today a reliable pathogenic hypothesis identifies the cause of NT1 as an autoimmune process destroying hypocretin-producing cells, there is no cure for narcolepsy, and the symptomatic pharmacological available treatments are not entirely effective for all symptoms. Behavioral therapies play a synergistic role in the disease treatment. We here review the available therapeutic options for narcolepsy, including symptomatic pharmacological treatments as well as behavioral and psychosocial interventions that could help clinicians improve the quality of life of patients with narcolepsy in adulthood and childhood.

KW - Adults

KW - Behavioral treatment

KW - Children

KW - Narcolepsy

KW - Pharmacological treatment

KW - Psychological treatment

UR - http://www.scopus.com/inward/record.url?scp=85068820092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068820092&partnerID=8YFLogxK

U2 - 10.1007/s11325-019-01894-4

DO - 10.1007/s11325-019-01894-4

M3 - Review article

C2 - 31290083

AN - SCOPUS:85068820092

JO - Sleep and Breathing

JF - Sleep and Breathing

SN - 1520-9512

ER -